GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, EGFR, ERBB2, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, NR1H4, PPARA |
9.50587 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, TYR, XDH |
8.42192 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, HSD17B1, HSD17B2, NR1H4 |
8.31412 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, APEX1, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KCNH2, KDR, MMP2, MMP9, NR1H4, PPARA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
8.197 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, FABP3, FUT7, GLO1, NR1H4, PIM1, PPARA, TYR, XDH |
8.17625 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, ADRA2C, ADRB1, AKR1B1, APEX1, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, XDH |
7.8975 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PIM1, PPARA, RORC, SRC, THRA, THRB |
7.5834 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, SRC, THRA, THRB |
7.53601 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP2, NR1H4, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, TYR, XDH |
7.2937 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, ADRA2C, ADRB1, AKR1B1, APEX1, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, KCNH2, KDR, MET, NR1H4, PPARA, SLC6A2, SLC6A4, SRC, TERT, THRA, THRB, XDH |
7.05926 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, APEX1, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, NR1H4, PPARA, RORC, SLC6A4, SRC, TYR |
6.83164 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.82567 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, HSD17B2, IGF1R, MMP2, MMP9, NR1H4, PPARA, RORC, SLC6A4, SRC, TYR |
6.82567 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, ADRA2C, ADRB1, AKR1B1, APEX1, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, XDH |
6.71815 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, NR1H4, RORC, SLC6A4, SRC, TYR |
6.65515 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRB1, AKR1B1, APEX1, AURKB, AXL, CA2, CA9, CACNA1C, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, TYR |
6.64867 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, SRC, THRA, THRB |
6.64867 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A6, TYR |
6.47203 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PPARA, PTPN1, SRC, TERT, THRA, TOP2A, XDH |
6.46986 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, APEX1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ERBB2, ESR1, ESRRA, FABP3, FLT3, IGF1R, MMP2, NR1H4, PPARA, SLC6A4, SRC |
6.40588 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PTPN1, SRC, TERT, THRA, TOP2A, XDH |
6.36712 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, XDH |
6.04853 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HSD17B1, HSD17B2, NR1H4 |
5.96947 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, PPARA, SRC, THRA, TYR |
5.96272 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.85761 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, APEX1, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, NR1H4, RORC, SLC6A4, SRC, TERT |
5.85226 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, CDC25B, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SLC6A4, SRC, TERT, XDH |
5.85226 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, KDR, MET, MMP12, MMP9, NR1H4, PTPN1, SRC, TERT, XDH |
5.82134 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, EGFR, ERBB2, FABP3, FABP4, FUT7, MET, PPARA |
5.82134 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, KDR, MET, MMP12, MMP9, NR1H4, PTPN1, SRC, TERT, XDH |
5.80466 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, IGF1R, KDR, MMP9, NR1H4, PIM1, PTPN1, SRC, TERT, THRA, TOP2A, XDH |
5.80466 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
5.72492 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AKR1B1, AKR1B10, ALOX5, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRB, FABP4, HSD17B2, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A2, SLC6A4, SRC, THRA, THRB, TYR |
5.69289 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, SRC, TERT |
5.6252 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, APEX1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, PPARA, SLC6A4, SRC |
5.62512 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, XDH |
5.47778 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19 |
5.47778 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRB1, AKR1B1, APEX1, AURKB, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KCNH2, KDR, MMP12, MMP2, MMP9, NR1H4, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, THRA, TOP2A, TYR |
5.415 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, APEX1, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, SLC6A4, SRC, TERT, THRA |
5.29993 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PPARA, PTPN1, SRC, TERT |
5.21051 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, ADRB1, AKR1B1, APEX1, AXL, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, FABP4, FLT3, KCNH2, MET, NR1H4, SRC, TERT |
5.18037 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, RORC, SLC6A4, SRC, TYR |
5.15542 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
5.11128 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
5.10045 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AURKB, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, XDH |
5.073 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
5.07055 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PTPN1, SRC, TERT |
4.99504 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AURKB, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, RORC, SRC, TERT, THRA, THRB, TOP2A, XDH |
4.99036 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
4.97514 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SRC, TERT, THRA, THRB, TOP2A, TYR, XDH |
4.93199 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19 |
4.90536 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, CACNA1C, EGFR, KCNH2, THRA, THRB |
4.86369 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, ADRB1, AKR1B1, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PTPN1, SLC6A4, SRC, TERT, THRA, XDH |
4.86369 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, HSD17B1, HSD17B2, TYR, XDH |
4.86314 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, APEX1, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, NR1H4, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A |
4.78076 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, ADRB1, AKR1B1, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PTPN1, SLC6A4, SRC, TERT, THRA, XDH |
4.75533 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, PPARA |
4.73364 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19 |
4.73298 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AURKB, CDC25B, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, RORC, SRC, TERT, THRA, THRB, TOP2A, XDH |
4.69651 |
[BP] GO:0032787 |
None
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, GLO1, NR1H4, PPARA |
4.68247 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ADRA2C, AURKB, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, XDH |
4.65581 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.6447 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
4.6447 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, NR1H4, RORC, SLC6A4, SRC |
4.57782 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AKR1B1, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, KDR, MET, MMP12, MMP9, NR1H4, PTPN1, SRC, TERT, XDH |
4.5633 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, RORC |
4.4972 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, IGF1R, KDR, MMP9, NR1H4, PIM1, PTPN1, SRC, TERT |
4.3767 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, FABP3, GLO1, NR1H4, PIM1, PPARA, TYR |
4.35529 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SRC, TERT, THRA, THRB, TOP2A, TYR, XDH |
4.29015 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, EGFR, ERBB2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, NR1H4, PTPN1, SLC6A4, SRC, TERT, XDH |
4.26412 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.26412 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, EGFR, ERBB2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, NR1H4, PTPN1, SLC6A4, SRC, TERT, XDH |
4.25499 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.25499 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, TERT |
4.22061 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.21048 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APEX1, CACNA1C, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MMP9, SRC, TERT |
4.17725 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, AXL, CA2, CACNA1C, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, KCNH2, KDR, MET, MMP12, MMP9, NR1H4, PIM1, SLC6A4, SRC, TERT, THRA, THRB, XDH |
4.13676 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, NR1H4, PPARA, RORC, SRC, TERT, THRA, THRB, TOP2A |
4.05278 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, NR1H4, PPARA, RORC, SRC, THRA |
4.02819 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, MMP9, NR1H4, PTPN1, SRC, XDH |
4.02505 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AKR1B1, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, ESRRA, FABP4, FLT3, KDR, MET, MMP12, MMP2, MMP9, NR1H4, PTPN1, SRC, TERT, XDH |
3.98658 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, EGFR, ESR1, PPARA, RORC, SLC6A4, SRC, TOP2A |
3.96028 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, FABP3, GLO1, NR1H4, PIM1, PPARA, TYR |
3.89579 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, ADRA2C, AXL, CA2, CA7, CACNA1C, CYP19A1, EGFR, ERBB2, KCNH2, MMP12, MMP9, NR1H4, PPARA, PTPN1, SLC6A4, SRC, TERT, THRA |
3.89579 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APEX1, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.87538 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, ADRB1, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FLT3, KDR, MMP9, NR1H4, PTPN1, SRC, XDH |
3.81957 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, ADRB1, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FLT3, KDR, MMP9, NR1H4, PTPN1, SRC, XDH |
3.81957 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, FABP3, GLO1, NR1H4, PIM1, PPARA, TYR |
3.81751 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
ADRB1, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, IGF1R, MET, MMP12, NR1H4, PPARA, PTPN1, RORC, SRC, TERT, THRA, THRB, TOP2A |
3.79779 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AKR1B1, AXL, CYP1B1, EGFR, ERBB2, FLT3, KDR, MET, PTPN1, SRC, XDH |
3.77001 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
3.73661 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19 |
3.73661 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, ADRA2C, ADRB1, EGFR, SLC6A4, SRC |
3.73661 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CACNA1C, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, TYR, XDH |
3.72666 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19 |
3.70486 |
[BP] GO:1901184 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, ERBB2, MMP9 |
3.70464 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CA9, CYP1A1, CYP1B1, EGFR, FABP3, KCNH2, KDR, SLC6A2, SLC6A4, SRC |
3.69705 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.66751 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB1, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MET, MMP12, NR1H4, PPARA, RORC, SRC, TERT, THRA, THRB, TOP2A |
3.62249 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, ESR1, IGF1R, MMP2, MMP9, NR1H4, RORC, SLC6A4, SRC |
3.59384 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, NR1H4, SLC6A4, SRC |
3.59384 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, NR1H4, PPARA |
3.58576 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APEX1, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.54925 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, EGFR |
3.54796 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR |
3.53794 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APEX1, CYP19A1, CYP1B1, EGFR, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.49237 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MET, MMP12, NR1H4, PPARA, RORC, SRC, TERT, THRA, THRB, TOP2A |
3.46579 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.46063 |
[BP] GO:0022414 |
reproductive process
|
ADRA2C, AKR1B1, AXL, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, MMP2, MMP9, SLC6A4, SRC, THRA, THRB, TOP2A |
3.4073 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, RORC, SLC6A4, SRC |
3.32237 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APEX1, EGFR, ERBB2, ESR1, FLT3, IGF1R, MMP2, NR1H4, SLC6A4, SRC |
3.29355 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, CA2, CACNA1C, EGFR, ERBB2, MMP12, NR1H4, PTPN1, SRC, THRA |
3.28123 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADRB1, AXL, CDC25B, CES1, CYP1A1, EGFR, ERBB2, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, KDR, MET, MMP2, MMP9, RORC, SRC, TERT, THRA, THRB, TOP2A |
3.24077 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, ADRB1, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, NR1H4, PPARA, PTPN1, SRC, XDH |
3.21114 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, ADRA2C, ADRB1, EGFR, SLC6A4 |
3.21114 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, ADRA2C, ADRB1, EGFR, SLC6A4 |
3.21114 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, CA2, CYP19A1, EGFR, ERBB2, KCNH2, MMP12, NR1H4, SLC6A4, SRC, TERT |
3.20704 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR |
3.19638 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.18723 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, ADRB1, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, NR1H4, PPARA, PTPN1, SRC, XDH |
3.17341 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, CACNA1C, EGFR, KDR, NR1H4, SRC |
3.1608 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KCNH2, KDR, SRC |
3.1201 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, ADRA2C, ADRB1, EGFR, SLC6A4 |
3.07567 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, TERT |
3.06859 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, ADRA2C, ADRB1, EGFR, SLC6A4 |
3.06197 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, ADRA2C, ADRB1, EGFR, SLC6A4, SRC |
3.05093 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, AURKB, CA2, CYP1A1, EGFR, MMP2, PPARA, SLC6A4, SRC, TERT, THRA, TYR |
3.03371 |
[BP] GO:0045742 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
2.99648 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP2C19 |
2.97153 |
[BP] GO:0045741 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.97153 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, NR1H4, PIM1, PPARA, PTPN1, SRC |
2.96812 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, APEX1, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, MMP2, MMP9, NR1H4, PPARA, PTPN1, SLC6A2, SLC6A4, SRC, TERT, THRA, TOP2A |
2.95556 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, CYP19A1, EGFR, ERBB2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, SRC, TERT, XDH |
2.95556 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CES1, CYP1A1, CYP1B1, KDR, SLC6A4, SRC |
2.9259 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, EGFR, ERBB2, FLT3, KDR, PTPN1, SRC, XDH |
2.9259 |
[BP] GO:1901186 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
2.92547 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, EGFR, FABP3, FLT3, IGF1R, MMP2, NR1H4, PPARA, SLC6A4, SRC, TYR |
2.89816 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.88045 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, CACNA1C, EGFR, KCNH2, THRA, THRB |
2.87677 |
[BP] GO:0008050 |
None
|
THRA, THRB |
2.86239 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.86239 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, MMP9 |
2.85602 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1B1, DAO, NR1H4, TYR |
2.84515 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, FABP4, FLT3, IGF1R, KDR, MET, MMP12, MMP2, MMP9, NR1H4, PPARA, PTPN1, SRC, TERT, THRA, XDH |
2.80832 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.79527 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, EGFR, ERBB2, ESR1, FLT3, MET, PIM1, SRC, TYR |
2.79181 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, APEX1, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, XDH |
2.78818 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, NR1H4, SRC |
2.78818 |
[BP] GO:0061098 |
None
|
ADORA1, ADRA2A, ADRA2C, PTPN1 |
2.78818 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, FLT3, PTPN1, SRC |
2.77977 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, MMP9, PIM1, PPARA, RORC, SRC, THRA, TYR |
2.73154 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.73154 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, NR1H4, PPARA |
2.73154 |
[BP] GO:0008016 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, KCNH2, THRA, THRB |
2.71872 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, FABP4, KCNH2, MET, NR1H4 |
2.69757 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.69676 |
[BP] GO:0045893 |
None
|
EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, MET, MMP12, NR1H4, PPARA, RORC, SRC, TERT, THRA, THRB, TOP2A |
2.68161 |
[BP] GO:1903508 |
None
|
EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, MET, MMP12, NR1H4, PPARA, RORC, SRC, TERT, THRA, THRB, TOP2A |
2.68161 |
[BP] GO:1902680 |
None
|
EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, MET, MMP12, NR1H4, PPARA, RORC, SRC, TERT, THRA, THRB, TOP2A |
2.67989 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.66199 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, ADRA2C, CACNA1C, CYP19A1, EGFR, MMP12, NR1H4, SLC6A4, SRC |
2.66199 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.65746 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.65746 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, EGFR, ERBB2, FLT3, IGF1R, PTPN1, SRC |
2.64584 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, EGFR, FABP3, FLT3, IGF1R, MMP2, NR1H4, PPARA, SLC6A4, SRC, TYR |
2.63942 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, AKR1B1, AXL, CA1, CA2, CACNA1C, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KCNH2, KDR, MET, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SRC, THRA, THRB |
2.61814 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, CACNA1C, EGFR, MMP12, NR1H4, SRC |
2.60537 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19 |
2.60341 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PTPN1, SRC, TERT, THRA, XDH |
2.56728 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, ADRA2C, FLT3, PTPN1, SRC |
2.53066 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, CDC25B, EGFR, ERBB2, ESRRB, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
2.52494 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, CYP19A1, EGFR, ESR1, FABP4, IGF1R, MET, MMP12, MMP2, NR1H4, PPARA, PTPN1, SRC, TERT, XDH |
2.52473 |
[BP] GO:0071396 |
cellular response to lipid
|
AXL, EGFR, ESR1, FLT3, NR1H4, RORC, SLC6A4, SRC |
2.52113 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT |
2.52066 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, PPARA, THRA |
2.52066 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
ADRB1, MMP1, MMP12, MMP2, MMP9 |
2.49872 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, EGFR, ERBB2, FLT3, IGF1R, KDR, PTPN1, SRC, XDH |
2.49565 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, ADRA2A, ADRA2C, CACNA1C, CYP19A1, EGFR, NR1H4 |
2.49136 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, APEX1, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SRC, TERT, THRA, THRB, TOP2A, XDH |
2.49136 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.49136 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.49136 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, EGFR, ERBB2, FLT3, PTPN1, SRC |
2.49136 |
[BP] GO:0051254 |
None
|
EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, MET, MMP12, NR1H4, PPARA, RORC, SRC, TERT, THRA, THRB, TOP2A |
2.48722 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, EGFR, ERBB2, PPARA |
2.48722 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.48722 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT |
2.46912 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APEX1, AURKB, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, FABP4, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, RORC, SRC, TERT, THRA, THRB, XDH |
2.4436 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.4436 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, CACNA1C, CYP19A1, EGFR, MMP12, NR1H4, SLC6A4, SRC |
2.44211 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CDC25B, CYP1A1, EGFR, SLC6A4, SRC, TERT |
2.43987 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, MMP9, TERT |
2.43444 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, CDC25B, EGFR, ERBB2, ESRRB, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.42918 |
[BP] GO:0071880 |
None
|
ADRA2A, ADRA2C, ADRB1 |
2.42918 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, NR1H4, SRC, TOP2A |
2.42675 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, ADRA2C, CACNA1C, CSNK2A1, EGFR, ERBB2, MMP12, NR1H4, PTPN1, SRC, TERT, THRA |
2.41305 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, EGFR, ERBB2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, NR1H4, PTPN1, SRC, TERT, XDH |
2.40583 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2C19, DAO |
2.4005 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, MMP12, NR1H4, SLC6A4, SRC |
2.36746 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, ADRA2C, ADRB1, AXL, CA2, CYP1B1, EGFR, ESRRB, KDR, MET, MMP12, MMP9, NR1H4, PIM1, SRC, TERT |
2.3404 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, APEX1, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SRC, TERT, THRA, THRB, TOP2A, XDH |
2.3387 |
[BP] GO:0071229 |
cellular response to acid chemical
|
EGFR, KDR, MMP2, NR1H4, SLC6A4, SRC |
2.32953 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.32069 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.32069 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.31812 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.31812 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, APEX1, AURKB, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, XDH |
2.31812 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.31379 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, APEX1, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SRC, TERT, THRA, THRB, TOP2A, XDH |
2.30551 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, EGFR, IGF1R, MMP2, NR1H4, SLC6A4, SRC |
2.28673 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT |
2.28154 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.27547 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27547 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, EGFR, ERBB2, FLT3, PTPN1, SRC |
2.27424 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, NR1H4, PPARA, SRC |
2.27424 |
[BP] GO:0051172 |
None
|
ADRA2A, APEX1, AURKB, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, FABP4, IGF1R, MMP12, MMP9, NR1H4, PPARA, PTPN1, RORC, SRC, TERT, THRA, THRB, XDH |
2.27424 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, SLC6A4 |
2.26992 |
[BP] GO:0035625 |
None
|
ADRA2A, ADRA2C |
2.26992 |
[BP] GO:0032811 |
None
|
ADRA2A, ADRA2C |
2.26992 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.26992 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.26992 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.26992 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AURKB, CDC25B, EGFR, ERBB2, ESR1, ESR2, FLT3, MET, MMP9, PTPN1, SRC, TERT, XDH |
2.26991 |
[BP] GO:0051223 |
None
|
ACHE, ADRA2A, ADRA2C, CACNA1C, EGFR, ERBB2, MMP12, NR1H4, PTPN1, SRC, THRA |
2.2542 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HSD17B1, HSD17B2 |
2.24452 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.24452 |
[BP] GO:0071875 |
None
|
ADRA2A, ADRA2C, ADRB1 |
2.24452 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.24452 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, MET, MMP9, PPARA, SRC, TERT |
2.24199 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, MMP12, MMP2, NR1H4, PPARA, PTPN1, SRC |
2.23846 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, EGFR, ERBB2, FABP4, FLT3, IGF1R, PTPN1, SRC |
2.23011 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, TERT |
2.22038 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, KDR, SRC |
2.21452 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, NR1H4, PTPN1, SRC |
2.20483 |
[BP] GO:0019219 |
regulation of nucleobase-containing compound metabolic process
|
ADORA3, ADRA2A, ADRB1, APEX1, AURKB, CA9, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, IGF1R, MET, MMP12, NR1H4, PIM1, PPARA, PTPN1, RORC, SRC, TERT, THRA, THRB, TOP2A |
2.18936 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, MET, SRC, XDH |
2.18518 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, CDC25B, EGFR, ERBB2, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
2.18518 |
[BP] GO:0006357 |
None
|
AURKB, CA9, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, GLO1, MET, MMP12, NR1H4, PPARA, RORC, TERT, THRA, THRB, TOP2A |
2.18317 |
[BP] GO:0045934 |
None
|
ADRA2A, APEX1, AURKB, ESR1, ESR2, ESRRA, FABP4, MMP12, NR1H4, PPARA, RORC, SRC, TERT, THRA, THRB |
2.17824 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1 |
2.16343 |
[BP] GO:0051253 |
None
|
APEX1, AURKB, ESR1, ESR2, ESRRA, FABP4, MMP12, NR1H4, PPARA, RORC, SRC, TERT, THRA, THRB |
2.15914 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, ADRA2C, CACNA1C, EGFR, MMP12, NR1H4, SRC |
2.12661 |
[BP] GO:0030154 |
cell differentiation
|
ADRB1, AXL, CES1, CYP1A1, ERBB2, ESR1, FABP4, FLT3, FUT7, GLO1, KDR, MMP2, MMP9, RORC, THRA, THRB, TOP2A |
2.12007 |
[BP] GO:1900078 |
None
|
ESRRA, NR1H4, SRC |
2.11392 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, EGFR, ERBB2, FLT3, PTPN1, SRC |
2.11392 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, EGFR, IGF1R, MMP2, NR1H4, SLC6A4, SRC |
2.10472 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, AXL, CYP1A1, EGFR, ESR1, SLC6A4, SRC, THRA, THRB |
2.10472 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, NR1H4, SRC |
2.10384 |
[BP] GO:0010038 |
response to metal ion
|
CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, TERT |
2.10036 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, ADRA2C, CACNA1C, EGFR, ERBB2, MMP12, NR1H4, PTPN1, SRC, THRA |
2.10036 |
[BP] GO:0035624 |
None
|
ADRA2A, ADRA2C |
2.10036 |
[BP] GO:0060509 |
None
|
THRA, THRB |
2.10036 |
[BP] GO:0014060 |
None
|
ADRA2A, ADRA2C |
2.10036 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, ADRA2C, AURKB, CDC25B, EGFR, ERBB2, FLT3, PTPN1, SRC |
2.09673 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.09407 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, AURKB, CDC25B, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, FABP4, FLT3, IGF1R, MET, MMP9, NR1H4, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
2.08756 |
[BP] GO:0061097 |
None
|
ADORA1, ADRA2A, ADRA2C, PTPN1 |
2.07373 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, FABP3, KCNH2, NR1H4, PPARA, SLC6A2, SLC6A4 |
2.06849 |
[BP] GO:0043433 |
negative regulation of DNA binding transcription factor activity
|
ADORA3, CYP1B1, ESR1, NR1H4, PIM1 |
2.06663 |
[BP] GO:0010628 |
positive regulation of gene expression
|
EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, MET, MMP12, NR1H4, PPARA, RORC, SLC6A4, SRC, TERT, THRA, THRB, TOP2A |
2.06527 |
[BP] GO:0007176 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.04762 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.0366 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, EGFR, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.0361 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.02465 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, ADRA2A, ADRB1, APEX1, AURKB, CA9, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, IGF1R, KDR, MET, MMP12, NR1H4, PIM1, PPARA, RORC, SRC, TERT, THRA, THRB, TOP2A |
2.02371 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.01072 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, EGFR, ERBB2, FABP4, FLT3, IGF1R, PTPN1, SRC |
2.00841 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, CA2, CA4, CA9, EGFR, ERBB2 |
3.28304 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA2C, ADRB1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, CA1, CA2, CA4, CA7, CACNA1C, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, EGFR, ERBB2, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, KCNH2, KDR, MMP2, MMP9, PIM1, PTPN1, SLC6A4, SRC, TERT, THRA, TOP2A, TYR, XDH |
2.65665 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, EGFR, ERBB2, ESR1, FLT3, GLO1, IGF1R, KCNH2, KDR, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A4, SRC, TERT |
2.15972 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
1.96993 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, ADRA2C, ADRB1, AKR1B1, AKR1B10, AOX1, APEX1, AURKB, AXL, CA1, CA2, CA4, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DAO, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, THRA, THRB, TOP2A, TYR, XDH |
1.76358 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, THRA, THRB, TYR, XDH |
17.7382 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, TYR, XDH |
11.6015 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.69925 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
9.50587 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
9.50587 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR1H4, PPARA, PTPN1, RORC, THRA, THRB |
9.19264 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
8.90643 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, EGFR, ERBB2, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, TERT, TOP2A, TYR, XDH |
8.61266 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, THRA, THRB, TOP2A, TYR, XDH |
8.197 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, THRA, THRB, TOP2A, TYR, XDH |
7.86248 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.76107 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KCNH2, KDR, MET, NR1H4, PPARA, RORC, THRA, THRB |
6.39143 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.30211 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.96272 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, HSD17B1, HSD17B2, TYR, XDH |
5.84857 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, XDH |
5.72492 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC, THRA |
5.70776 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KCNH2, KDR, MET, NR1H4, PPARA, RORC, THRA, THRB |
5.62512 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, EGFR, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, THRA |
5.44729 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KCNH2, KDR, MET, NR1H4, PPARA, RORC, THRA, THRB |
5.415 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.415 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.29785 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1, NR1H4, RORC |
5.18374 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
5.07253 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ADRB1, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KCNH2, KDR, MET, NR1H4, PPARA, RORC, THRA, THRB |
4.98949 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, TYR |
4.95697 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.32333 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, SRC |
4.20159 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, ADRA2C, AOX1, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MET, MMP9, SLC6A4, TERT, TOP2A, TYR, XDH |
4.12848 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.02505 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, THRA, THRB |
4.01823 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, SRC |
4.01578 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, HSD17B1, SRC, XDH |
3.84465 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SLC6A4, SRC, TOP2A |
3.78546 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, ADRA2C, ADRB1, AOX1, AXL, DAO, EGFR, ERBB2, FLT3, KCNH2, SLC6A4, TERT, TOP2A, TYR, XDH |
3.78275 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, TYR |
3.73661 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.72917 |
[MF] GO:0004887 |
None
|
NR1H4, THRA, THRB |
3.65499 |
[MF] GO:0051379 |
None
|
ADRA2A, ADRA2C, ADRB1 |
3.47978 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
3.47675 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.32237 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AOX1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, IGF1R, KDR, MET, MMP12, NR1H4, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, XDH |
3.24333 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A6, CYP2C19 |
3.12607 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B1, HSD17B2, XDH |
3.0139 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, ADRB1, AURKB, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP2C19, EGFR, ERBB2, ESR1, ESR2, ESRRB, KCNH2, MET, PPARA, PTPN1, SLC6A4, SRC, THRB, TOP2A |
2.95556 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.86239 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.78882 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.75231 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HSD17B1, NR1H4, PPARA, RORC |
2.68698 |
[MF] GO:0004935 |
None
|
ADRA2A, ADRA2C, ADRB1 |
2.65746 |
[MF] GO:0031690 |
None
|
ADRA2A, ADRA2C, ADRB1 |
2.52066 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, ESR1, ESRRB, FLT3, NR1H4, PIM1, PPARA, SRC, TERT, THRA |
2.49565 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.49136 |
[MF] GO:0004938 |
None
|
ADRA2A, ADRA2C |
2.49136 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.49136 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.49136 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.48722 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC, TERT |
2.46864 |
[MF] GO:1901338 |
None
|
ADRA2A, ADRA2C, ADRB1 |
2.42918 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.42918 |
[MF] GO:0046982 |
protein heterodimerization activity
|
ADORA1, ADRA2A, ADRA2C, ADRB1, AXL, EGFR, ERBB2, TOP2A, TYR |
2.36074 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DAO, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, IGF1R, KDR, MET, MMP12, NR1H4, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, THRA, THRB, TOP2A, XDH |
2.3387 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.26992 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.26992 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, ADRA2C, AOX1, FLT3, KCNH2, SLC6A4, TERT, TOP2A, TYR, XDH |
2.21452 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.10036 |
[MF] GO:0051380 |
None
|
ADRA2A, ADRB1 |
2.10036 |
[MF] GO:0031694 |
None
|
ADRA2C, ADRB1 |
2.10036 |
[MF] GO:0052689 |
carboxylic ester hydrolase activity
|
ACHE, CA1, CA2, CES1, CES2 |
2.05485 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CSNK2A1, DAO, EGFR, ERBB2, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, NR1H4, PIM1, SRC, TOP2A, XDH |
2.0124 |